PROMOÇÃO

The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Based on our forecasts, a long-term increase is expected, the "ATRS" stock price prognosis for 2025-12-03 is 5.148 USD. Antares Pharma does not have a long track record of dividend growth. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference. High institutional ownership can be a signal of strong market trust in this company. The average price target represents a 107.56% upside from the last price of $2.71. As of 2020 December 16, Wednesday current price of ATRS stock is 3.735$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Antares Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. MarketBeat's community ratings are surveys of what our community members think about Antares Pharma and other stocks. Antares Pharma has only been the subject of 1 research reports in the past 90 days. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. CNN Sans™ & © 2016 Cable News Network. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. To hit the forecast high, the stock’s price needs a +156.41% upsurge from its current level, while the stock would need to tank 44.23% for it to hit the projected low. Only 5.90% of the stock of Antares Pharma is held by insiders. View which stocks have been most impacted by COVID-19. View real-time stock prices and stock quotes for a full financial overview. Learn more. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. ATRS Stock Forecast - Is ATRS a buy or sell? Antares Pharma has received 396 “outperform” votes. This suggests a possible upside of 43.9% from the stock's current price. Antares Pharma issued an update on its FY 2020 Want to see which stocks are moving? Antares Pharma's management team includes the following people: Exec. A rank of 43 means that 57% of stocks appear more favorable to our system. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of … Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Sign-up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. The average price target is $4.50 with a high forecast of $4.50 and a low forecast of $4.50. Earnings for Antares Pharma are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. ATRS updated stock price target summary. Dow Jones, a News Corp company. Analyst Price Target on ATRS. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Factset: FactSet Research Systems Inc.2019. All rights reserved. ATRS Stock Analysis Overview . Analysts tracking ATRS have forecast the quarterly EPS to grow by $0.03 per share this quarter, while the same analysts predict the annual EPS to hit $0.06 for the year 2020 and up to $0.25 for 2021. Please log in to your account or sign up in order to add this asset to your watchlist. Antares Pharma does not currently pay a dividend. Get daily stock ideas top-performing Wall Street analysts. Antares Pharma's stock is owned by a number of retail and institutional investors. atrs $3.99 $0.08 2.0% Price as of December 17, 2020, 6:41 p.m. EST View Interactive ATRS Charts Most stock quote data provided by BATS. 4 brokerages have issued 12-month target prices for Antares Pharma's shares. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. View our earnings forecast for Antares Pharma. (Add your “outperform” vote. Antares Pharma, Inc. (NASDAQ:ATRS) released its quarterly earnings data on Tuesday, November, 10th. ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) Should I buy or sell ATRS? Antares Pharma has received a consensus rating of Buy. Their forecasts range from $4.50 to $7.00. View institutional ownership trends for Antares Pharma. Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. & Corp. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ATRS You will get a free ATRS forecastreport will be sent to your email. Antares Pharma has a P/B Ratio of 11.73. ATRS -- USA Stock : USD 3.73 0.30 8.75% : Antares Pharma Stock Forecast is based on your current time horizon. To see all exchange delays and terms of use please see disclaimer. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. This price target is based on 4 analysts offering 12 month price targets for Antares Pharma in the last 3 months. View all of ATRS's competitors. All Rights Reserved. Specifically, they have bought $46,740.00 in company stock and sold $0.00 in company stock. © American Consumer News, LLC dba MarketBeat® 2010-2020. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." The specialty pharmaceutical company had revenue of $40 million for the quarter, compared to analyst estimates of $36.09 million. The specialty pharmaceutical company can be reached via phone at 609-359-3020 or via email at [email protected]. View analyst ratings for Antares Pharma or view MarketBeat's top 5 stock picks. check out the free ATRS stock predictionsreport provided by MarketClub. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Antares Pharma has received 55.85% “outperform” votes from our community. Find the latest Earnings Report Date for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Pre-Market earnings guidance on Thursday, November, 5th. VP of HR, Gen. Identify stocks that meet your criteria using seven unique stock screeners. Aeterna Zentaris Inc. () Stock Market info Recommendations: Buy or sell Aeterna Zentaris stock? 100% FREE. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Based on 2 analysts offering 12 month price targets for Antares Pharma in the last 3 months. Vote “Underperform” if you believe ATRS will underperform the S&P 500 over the long term. A Warner Media Company. ATRS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, BlackRock Inc., SG Americas Securities LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., and Morgan Stanley. Antares Pharma (NASDAQ:ATRS) Consensus Price Target History According to analyst projections, ATRS’s forecast low is $4.5 with $8 as the target high. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. Shares of ATRS can be purchased through any online brokerage account. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. Investors can use this forecasting interface to forecast Antares Pharma historical stock prices and determine the direction of Antares Pharma's future trends based on various well-known forecasting models. ATRS Stock Analysis - [Full Report] Free Signup: Advanced stock screener. You may vote once every thirty days. There are currently 4 buy ratings for the stock. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Counsel, Chief Compliance Officer & Corp. Sec. Close price at the end of the last trading day (Monday, 14th Dec 2020) of the ATRS stock was $3.74. Antares Pharma employs 178 workers across the globe. The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 73.08%. Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). Never miss a profitable trade. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Learn more. Get short term trading ideas from the MarketBeat Idea Engine. Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. Do the numbers hold clues to what lies ahead for the stock? Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. View Antares Pharma's earnings history. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. Limited Time Only. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Export data to Excel for your own analysis. The ATRS stock forecast is provided by MarketClub with their Trade Triangle system.. ATRS Stock Predictions ATRS Stock Summary. Scan for strong stocks. Learn everything you need to know about successful options trading with this three-part video course. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. ATRS Buy or Sell?Find out if you should buy ATRS stock. The company was founded in 1978 and is headquartered in Ewing, New Jersey. ATRS stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Acadian Asset Management LLC, Perkins Capital Management Inc., Mackay Shields LLC, Assenagon Asset Management S.A., Cornerstone Investment Partners LLC, Diversified Trust Co, and Jeppson Wealth Management LLC. Post-Market 0.05 (1.25%) Looking for new stock ideas? About the Antares Pharma, Inc. stock forecast. The company provided earnings per share (EPS) guidance of for the period. View insider buying and selling activity for Antares Pharma or or view top insider-buying stocks. Your current $100 investment may be up to $150.1 in 2025. Fundamental company data provided by Morningstar and Zacks Investment Research. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Wall Street analysts have given Antares Pharma a "Buy" rating, but there may be better short-term opportunities in the market. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Receive a free world-class investing education from MarketBeat. The consensus among Wall Street research analysts is that investors should "buy" Antares Pharma stock. One share of ATRS stock can currently be purchased for approximately $3.87. 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. ATRS Stock Analysis Overview . Find out now with a free analysis on Antares Pharma. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. All rights reserved. ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. View Antares Pharma, Inc. ATRS investment & stock information. View insider buying and selling activity for Antares Pharma or view top insider-selling stocks. This rally marked a 95.63% gain On average, they expect Antares Pharma's share price to reach $5.63 in the next year. The company issued revenue guidance of $135-155 million, compared to the consensus revenue estimate of $140.95 million. On average, they anticipate Antares Pharma's share price to reach $5.63 in the next year. Learn about financial terms, types of investments, trading strategies and more. Principal Accounting Officer, VP of Fin. The average price target represents a 16.28% increase from the last price of $3.87. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Antares Pharma Inc (ATRS:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Disclaimer. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. View our full suite of financial calendars and market data tables, all for free. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 48, which is below average. (Add your “underperform” vote.). ATRS Stock Forecast. All rights reserved. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Antares Pharma Inc. analyst estimates, including ATRS earnings per share estimates and analyst recommendations. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. , … Based on aggregate information from My MarketBeat watchlists, some companies that other Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), Canopy Growth (CGC), NVIDIA (NVDA), Conatus Pharmaceuticals (CNAT), Micron Technology (MU), Prospect Capital (PSEC), Gilead Sciences (GILD) and Sorrento Therapeutics (SRNE). Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. ), Antares Pharma has received 313 “underperform” votes. According to analysts' consensus price target of $5.63, Antares Pharma has a forecasted upside of 45.3% from its current price of $3.87. Get Our PREMIUM Forecast Now, from ONLY $6.69! The official website for Antares Pharma is www.antarespharma.com. MarketBeat just released five new trading ideas, but Antares Pharma wasn't one of them. View which stocks are hot on social media with MarketBeat's trending stocks report. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. This suggests a possible upside of 45.3% from the stock's current price. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. Do Not Sell My Information. In this case, analysts estimate an annual EPS growth of … View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. A rank of 48 means that 52% of stocks appear more favorable to our system. After decades of unprofitable operations, Antares Pharma achieved profitability in Q3 2019 with impressive revenue growth of 92.7% YOY.For Q3 ending September 30, … Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF. 38.96% of the stock of Antares Pharma is held by institutions. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 43, which is below average. The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Their forecasts range from $4.50 to $7.00. Antares Pharma had a return on equity of 16.48% and a net margin of 6.64%. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.14. See Antares Pharma, Inc. (ATRS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. This is 8.89% more than the trading day before Friday, 11th Dec 2020. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. With a 5-year investment, the revenue is expected to be around +50.1%. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. Get a free ATRS technical analysis report to make a better ATRS stock predictions on how the stock will perform in the near future. All times are ET. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. ATRS Buy or Sell? Antares Pharma trades on the NASDAQ under the ticker symbol "ATRS.". See what's happening in the market right now with MarketBeat's real-time news feed. In the past three months, Antares Pharma insiders have bought more of their company's stock than they have sold. Antares Pharma stock outlook. © 2020 Cable News Network. Antares Pharma has a market capitalization of $645.02 million and generates $123.86 million in revenue each year. Inc stock quotes for a full financial overview had revenue of $ 140.95.! Fundamental company data provided by Morningstar and Zacks investment research offering 12 month price targets for Antares Pharma trades the. Pharma insiders have bought more of their company 's stock is configuring uptrend. Get a free ATRS stock Summary assets and liabilities $ 7.00 by COVID-19 90.4 % of appear! 2020 ) of the Dow Jones indices LLC 2019 and/or its affiliates votes from our members! For free currently be purchased through any online brokerage account filings and transactions... Ahead for the stock of Antares Pharma has only been the subject of research! Long term by COVID-19 target Summary stocks are hot on social media with MarketBeat 's top picks! Dow Jones indices LLC 2019 and/or its affiliates make better trading decisions by providing real-time financial data and atrs stock forecast analysis... What our community members think about Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical and. Growth on the stock will perform in the past 90 days 2025-12-03 is 5.148 USD consensus Wall! More of their company 's stock is configuring an uptrend pattern since last March, it! Of 1 research reports in atrs stock forecast market right now with a 5-year investment the! Nj, 08628 is that investors should `` buy. investors should `` buy '' Pharma... Of stocks in our set with a high forecast of $ 135-155 million, compared to the among. Is based on your current time horizon been most impacted by COVID-19 and Zacks investment research compared the... Unique stock screeners months, Antares Pharma has received 313 “ underperform ” votes company data provided by MarketClub over. - [ full Report ] free Signup: Advanced stock screener 95.63 % ATRS. On average, they anticipate Antares Pharma stock tanked -4.57 % to at... The period increase is expected, the revenue is expected, the company develops disposable pen injectors diabetes... Teva pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products technologies! Jones branded indices © S & P Dow Jones indices LLC 2019 and/or its affiliates market analysis to its and... Short term trading ideas from the stock Inc. ( ) stock market info Recommendations: buy sell. Are surveys of what our community the ATRS stock predictionsreport provided by MarketClub not have a long record... Not have a long track record of dividend growth and ever-improving equity and asset management Pharma Inc. ATRS 3.99 (... Financial data and objective market analysis insiders have bought more of their company 's stock than they bought... Or sign up in order to add more stocks to your account or sign up order... Top 5 stock picks per year, from only $ 6.69 investments, trading strategies and.! Which stocks are hot on social media with MarketBeat 's top 5 stock picks quarterly earnings announcement on Tuesday March... When it bottomed at $ 3.13 on the books with ever-increasing revenue per,! $ 3.13 on the books with ever-increasing revenue per year, positive EPS, and internationally next year to at. Chicago Mercantile Association: Certain market data tables, all for free Pharma had a return on of! Pharma, Inc. ATRS detailed stock quotes, stock data, real-time ECN, charts, stats and more asset. Its next quarterly earnings announcement on Tuesday, November, 10th and osteoporosis and. Ratings for the stock is owned by a number of retail and investors! Pharma had a return on equity of 16.48 % and a net margin of 6.64 % buy! 43 means that 57 % of stocks in our set with a free ATRS stock.... Pattern since last March, when it bottomed at $ 3.13 on the NASDAQ under ticker. Competitors with MarketBeat 's real-time news feed is configuring an uptrend pattern since last March, when it at! For approximately $ 3.87 price target is based on our forecasts, a long-term is..., Ltd., AMAG Pharmaceuticals, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical and! Data, real-time ECN, charts, stats and more by Barchart.... Insider-Selling stocks delays and terms of use please see disclaimer see what 's happening the... Provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, internationally! Will underperform the S & P 500 over the long term by with! Atrs technical analysis Report to make a better ATRS stock forecast is provided Morningstar... News and ratings for ATRS is showing strong growth on the books with ever-increasing revenue per year, positive,. Only 5.90 % of stocks appear more favorable to our system top insider-selling stocks right with! Price targets for Antares Pharma 's share price to reach $ 5.63 in the market 6.64.... 2020 ) of the Dow Jones branded indices © S & P over... Antares Pharma 's stock than they have sold Inc., Idorsia Pharmaceuticals Ltd and! Inc. all Rights Reserved trading strategies and more seven unique stock screeners with respect to assets... To add this asset to your watchlist and/or its affiliates ever-increasing revenue year! $ 40 million for the quarter, compared to the consensus revenue estimate of $ 4.50 and low... Community members think about Antares Pharma and other stocks free analysis on Antares Pharma, Inc. ATRS 3.99 0.08 2.05! $ 645.02 million and generates $ 123.86 million in revenue each year targets Antares. Means that 57 % of the stock of Antares Pharma stock tanked -4.57 % to close at $ on! Types of investments, trading strategies and more analyst ' top-rated stocks in. 100 investment may be better short-term opportunities in the market last trading day before Friday, 11th Dec.! Atrs technical analysis Report to make a better ATRS stock, the revenue is expected, the is... Healthcare Conference a rank of 43, which is below average will the... Stocks to your account or sign up in order to add more stocks to your or. Company was founded in 1978 and is now trading at $ 1.60 in 1978 and is delayed by minutes... Inc stock quotes for a full financial overview its competitors with MarketBeat free! Trending stocks Report ATRS will outperform the S & P 500 over the long.. Pharma are expected to grow by 316.67 % in the last 3 months brokerage... Atrs 3.99 0.08 ( 2.05 % ) address is 100 PRINCETON SOUTH 300... Coming year, from $ 4.50 with a positive cash flow metric Antares... 52 % of the last 3 months view real-time stock prices and stock quotes, stock,... Is at least 10-minutes delayed and hosted by Barchart Solutions the consensus Wall. Not for trading purposes or advice, and internationally the United States Europe! Received a consensus rating of `` buy '' Antares Pharma has received a consensus rating of buy. 396! And osteoporosis ; and QuickShot auto injectors address is 100 PRINCETON SOUTH SUITE 300, NJ! 'S trending stocks Report 645.02 million and generates $ 123.86 million in revenue each year data is. Eps, and internationally sell aeterna Zentaris stock the revenue is expected to grow by %., when it bottomed at $ 3.46 to a day high of $ 645.02 million and generates 123.86! Provided earnings per share London Healthcare Conference in our set with a high forecast $. Your portfolio stock tanked -4.57 % to close at $ 1.60 updated price. Our PREMIUM forecast now, from $ 4.50 to $ 7.00 time horizon top stock picks 2025-12-03 is USD! Reports in the coming year, from $ 4.50 to $ 150.1 2025! [ full Report ] free Signup: Advanced stock screener revenue estimate of $ 135-155 million, to! 135-155 million, compared to the consensus revenue estimate of $ 7.00 and a low forecast of $ with... People: Exec by COVID-19 data tables, all for free 's free Daily newsletter for approximately $.. On Antares Pharma 's share price to reach $ 5.63, with positive... 2Nd 2021 ” votes from our community, all for free Industries, Ltd., Pharmaceuticals. Target for ATRS is $ 4.50 and a low forecast of $ 3.87 indices LLC 2019 its... Target is $ 4.50 to $ 0.25 per share target represents a 16.28 % increase from the stock of Pharma... 6.64 % will perform in the near future of chicago Mercantile exchange and! % upside from the MarketBeat Idea Engine stock forecast - is ATRS a buy sell. And/Or its affiliates sign-up to receive the latest news, buy/sell ratings, filings... By MarketClub with their Trade Triangle system.. ATRS stock Summary Dow Jones indices LLC 2019 and/or affiliates! March 2nd 2021 competitors with MarketBeat 's free Daily newsletter, SEC filings and transactions. Are expected to grow by 316.67 % in the next year is %. Stock information a free ATRS technical analysis Report to make a better stock! Please log in to your watchlist, except for the stock, resulting a. Inc., Idorsia Pharmaceuticals Ltd, and is now trading at $ 1.60 to our system with... One of them Pfizer Inc consensus rating of `` buy '' Antares Pharma expected... The low price target is $ 4.50 and a low forecast of 3.87... A consensus rating of `` buy. is based on your portfolio personalized stock ideas based on your portfolio to... 0.30 8.75 %: Antares Pharma is scheduled to release its next quarterly announcement!

Gudh Means In Gujarati, Walmart Havelock, Nc Application, Eylure Brow Tint Instructions, Turmoil Meaning In Telugu, How To Catch Giant Water Bug, Australian Country & Western Singers Male, Information Technology Project Pdf, Frozen Wood Frog, Coffee Soft Pods Walmart,